- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02903433
Effects of Avocado Intake on the Nutritional Status of Families
April 3, 2020 updated by: Matthew Allison, University of California, San Diego
Avocados are an excellent source of fiber, potassium, magnesium, and poly- and mono-unsaturated fats.
They can be a nutrient dense component of healthful dietary patterns and have the potential to improve the cardiovascular disease (CVD) risk profiles of families in the United States (US).
The proposed research plan will focus on the contribution of avocado intake to the reduction in CVD risk of US families, by examining the effects of avocado intake on the overall nutritional status of families.
Of particular interest is establishing these effects in ethnic populations such as Hispanics/Latinos.
On average, Hispanic/Latinos are at increased risk for metabolic diseases that predispose to CVD.
This 6-month cluster randomized trial in Hispanic/Latino Americans aims to accurately determine the impact of avocados on the overall dietary pattern of their families.
Future research will extend the results of the current trial to a larger sample of ethnically diverse families in order to evaluate whether sustained changes occur in nutritional, cardiovascular and metabolic health status.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Specific Aim 1: To determine how avocados are incorporated into the family's dietary pattern and impact selected measures of nutritional status:
- To determine if avocado intake substitutes for, or adds to, other sources of calories in the family diet.
- To determine if avocado intake helps reduce between-meal snacking of family members.
- To determine if avocados help families meet US Dietary Guidelines for recommended intake of: poly- and monounsaturated fats; vegetables; fiber; selected nutrients (vitamins C, D and E, Folate, Calcium, Magnesium, potassium, iron); lutein and other carotenoids.
Specific aim 2: To determine if increased avocado intake affects cardio-metabolic risk factors to include lipids, glucose, insulin, and HbA1c.
Study Type
Interventional
Enrollment (Actual)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Chula Vista, California, United States, 91910
- South Bay Latino Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be part of a family that consists of at least 3 individuals, but no more than 8, who reside in the same home
- Self-identify as Latino or Hispanic
- Be older than 5 years of age
Exclusion Criteria:
- Families with members who have clinically severe chronic diseases requiring specific diets (e.g. stage IV congestive heart failure, chronic kidney disease requiring dialysis)
- Those allergic to avocados
- Those with LATEX allergy
- Families who are already high consumers of avocados (i.e. more than 1 avocado per adult and more than ½ avocado per child per day);
- Those who are unwilling to eat avocados.
- Family members with nursing or pregnant females or females planning to become pregnant
- Family members under the age of 5 years will not be counted toward the number of family members who will be expected to participate in the intervention (i.e., adhere to healthy diet tips or consume avocados)
- Families intending to move, or which include family members intending to move, within the next 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High Intake Group
Throughout the entire study, this group will be provided with 14 avocados per week and will receive 12 bi-weekly home visits over a 6-month period during which they will receive specific brochures offering "diet tips".
This group will be given specific advice on avocado consumption.
Each month throughout the study, we will provide opportunities for families to visit the study kitchen at the SYHC to observe the staff preparing recipes with avocado, participate in preparing recipes, and taste recipes.
|
Families will receive 14 avocados on a weekly basis.
Diet tips will come from educational materials including culturally appropriate dietary and nutritional education materials, and personalized recommendations taken from http://www.choosemyplate.gov.
Recipe book with healthy recipe suggestions that include avocado.
|
|
Active Comparator: Low Intake Group
This group will receive 3 avocados per week, as well as 12 bi-weekly home visits over a 6-month period during which they will be provided with the same educational materials (i.e., "Diet Tips") as those assigned to the "High intake" group.
Participants in this group will be encouraged to improve the quality of their diets, but will not be given specific advice on avocado consumption.
However, each month throughout the study, we will provide opportunities for families to visit the study kitchen at the SYHC to observe the staff preparing recipes with avocado, participate in preparing recipes, and taste recipes.
|
Diet tips will come from educational materials including culturally appropriate dietary and nutritional education materials, and personalized recommendations taken from http://www.choosemyplate.gov.
Recipe book with healthy recipe suggestions that include avocado.
Families will receive 3 avocados on a weekly basis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in family energy consumption at 3 and 6 months
Time Frame: 3 months and 6 months
|
3 months and 6 months
|
|
Change in distribution of macro and micronutrient intake at 6 months
Time Frame: 3 months and 6 months
|
3 months and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in cardio-metabolic risk factors by serum lipids at 6 months
Time Frame: 3 months and 6 months
|
3 months and 6 months
|
|
Change in cardio-metabolic risk factors by insulin at 6 months
Time Frame: 3 months and 6 months
|
3 months and 6 months
|
|
Change in cardio-metabolic risk factors by glucose at 6 months
Time Frame: 3 months and 6 months
|
3 months and 6 months
|
|
Change in cardio-metabolic risk factors by computation of homeostasis model assessment at 6 months
Time Frame: 3 months and 6 months
|
3 months and 6 months
|
|
Change in nutritional status by red blood cell fatty acid composition at 6 months
Time Frame: 3 months and 6 months
|
3 months and 6 months
|
|
Change in nutritional status by red blood cell magnesium at 6 months
Time Frame: 3 months and 6 months
|
3 months and 6 months
|
|
Change in nutritional status by serum total and fractionated carotenoids at 6 months
Time Frame: 3 months and 6 months
|
3 months and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Matthew A Allison, MD, MPH, University of California, San Diego
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 20, 2017
Primary Completion (Actual)
January 8, 2019
Study Completion (Actual)
January 8, 2019
Study Registration Dates
First Submitted
September 2, 2016
First Submitted That Met QC Criteria
September 12, 2016
First Posted (Estimate)
September 16, 2016
Study Record Updates
Last Update Posted (Actual)
April 7, 2020
Last Update Submitted That Met QC Criteria
April 3, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 160584
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingCardiovascular Disease (CVD) | Gender Incongruence | Cardiovascular (CV) Risk | Cardiovascular Health Status | Cardiovascular Disease Prevention | Cardiovascular Disease Acute | Cardiovascular Disease Risk FactorItaly
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
University College DublinBeacon Hospital, IrelandRecruitingCoronary Artery Disease (CAD) | Cardiovascular Diseases (CVD) | Cardiovascular Disease Prevention | Cardiovascular Disease Risk FactorIreland
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Istituti Clinici Scientifici Maugeri SpAA.R.C.A Associazioni Regionali Cardiologi AmbulatorialiRecruiting
-
AmgenRecruitingCardiovascular DiseaseItaly, Germany, United States, China, Japan, Spain, Denmark, Australia, France, Canada, Netherlands
-
University of ReadingBiotechnology and Biological Sciences Research Council; Royal Berkshire NHS...Not yet recruiting
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
Clinical Trials on High-intake avocados
-
Medical University of BialystokMinistry of Science and Higher Education, PolandCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome | Diet Modification | Overweight and Obesity | Genetic PredispositionPoland
-
University of AarhusAarhus University Hospital; University of East Anglia; Kolding SygehusCompleted
-
Texas State UniversityCompletedArterial Stiffness | Sodium IntakeUnited States
-
Medical University of ViennaCompleted
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompletedAutosomal Dominant Polycystic KidneyUnited States
-
Carmine ZoccaliCompletedEssential Hypertension.
-
University of LausanneUniversity Hospital Inselspital, BerneCompleted
-
University of Sao PauloUnknownCancer | Surgery | Critically IllBrazil
-
University of California, San DiegoCompleted
-
University of CopenhagenDairy Farmers of Canada; The Danish Dairy Research Foundation, Denmark; Dairy... and other collaboratorsCompleted